fbpx
News
November 5, 2013

In the News Today – November 5, 2013

Johnson & Johnson agreed to pay $2.2 billion to settle a DOJ investigation into the marketing of its antipsychotic drug Risperdal. Washington Post

Talks between the DOJ and JPMorgan are underway again, and sources say a deal could be finalized this week. “We will either have an agreement or we will be filing a lawsuit,” said AG Eric Holder. American Lawyer

A lawyer who invested more than $6 million in a lawsuit against Chevron testified that he left the case amid concerns about possible unethical conduct. Bloomberg

Supreme Court Qui Tam Action Blog Supreme Court to Review Qui Tam Action Dismissal Standards  False Claims Act (FCA) Blog Law 360 Expert Analysis: "False Claims Act Proposal Is Unfair And Would Hinder Economic Growth" False Claims Act (FCA) U.S. Department of Justice building in Washington D.C. News Reuters "Has An Investor-Backed FCA Whistleblower Reached The End of the Road?" False Claims Act (FCA) U.S. Department of Justice building in Washington D.C. Blog Flying Blind: Secret Funding in Government Lawsuits and What to Do About It False Claims Act (FCA), Third Party Litigation Funding (TPLF) News On Appeal, Justice Dept. Prevails In Bid To Dismiss Pharma Fraud Case False Claims Act (FCA)

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings